Effect of Upstream High Bolus Dose of Tirofiban in Primary PCI for the Patients With STEMI on Short Term Outcome

• Status: Not yet recruiting
• Trial end date: 2022-01-28
• Target enrollment: 0
• Participant gender: All

Summary

The goal of the study to investigate the impact of upstream HBD of Tirofiban on short outcome of STEMI patient.

• Phase: Phase 1/Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Assiut University
• Treatments: Tirofiban

Criteria

Inclusion Criteria:

• - Acute STEMI patient within 12 hours of chest pain

Exclusion Criteria:

• -previous infarction in the same infarct- related artery

• ISR

• Resistent cardiogenic shock

• Known CKD with Cr cl less than 60 ml/min

• Uncontrolled HTN more than 180/110 mmHg

• Suspected aortic dissection

• Traumatic or prolonged CPR

• Severe trauma or major surgery within 3 month

• Active peptic ulcer within past 3 month

• Known history of coagulopathy